Kucerova, L., Demkova, L., Skolekova, S., Bohovic, R., & Matuskova, M. (2016). Tyrosine kinase inhibitor SU11274 increased tumorigenicity and enriched for melanoma-initiating cells by bioenergetic modulation. BMC Cancer.
শিকাগো স্টাইলে সাইটেশনKucerova, Lucia, Lucia Demkova, Svetlana Skolekova, Roman Bohovic, এবং Miroslava Matuskova. "Tyrosine Kinase Inhibitor SU11274 Increased Tumorigenicity and Enriched for Melanoma-initiating Cells By Bioenergetic Modulation." BMC Cancer 2016.
এমএলএ সাইটেশনKucerova, Lucia, et al. "Tyrosine Kinase Inhibitor SU11274 Increased Tumorigenicity and Enriched for Melanoma-initiating Cells By Bioenergetic Modulation." BMC Cancer 2016.
সতর্কবাণী: সাইটেশন সবসময় 100% নির্ভুল হতে পারে না.